Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.133.91.217
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Movement Disorders
Video
Early screening, diagnosis is crucial for patients with CTX
Peer-related discomfort linked to stress in children on growth hormone therapy
Tumor location affects survival in small intestine cancer, study finds
American College of Medical Genetics and Genomics Annual Meeting dives into tailored therapies for CTX and SLOS
Atypical case of CTX challenges diagnostic standards
-Advertisement-
IgG4-RD

The U.S. Food and Drug Administration approved inebilizumab-cdon as the first and only treatment for IgG4-related disease, a rare, chronic immune-mediated inflammatory condition that affects multiple organs. The approval was based on results...

-Advertisement-
-Advertisement-
-Advertisement-
Homozygous Familial Hypercholesterolemia (HoFH)

A recent poster presented at the 2025 American College of Cardiology's Annual Scientific Session evaluated surgical outcomes in patients with homozygous familial hypercholesterolemia (HoFH) undergoing aortic valve replacement (AVR). Researchers analyzed data from 134...

-Advertisement-
-Advertisement-
-Advertisement-
Growth Hormone Deficiency
-Advertisement-
-Advertisement-
-Advertisement-

Polls & Quizzes

Hypoparathyroidism: Long-Term Complications
Jan 31, 2025

Podcasts

Dr. Gloria Wu Podcast: Eliminating The Negative
May 30, 2024

Quizzes

Hypoparathyroidism: Long-Term Complications
Jan 31, 2025

Videos

Early screening, diagnosis is crucial for patients with CTX
Apr 09, 2025
-Advertisement-
-Advertisement-
-Advertisement-
Inherited Retinal Diseases

While sponsored genetic testing panels improve access to molecular diagnosis for inherited retinal diseases (IRD), significant challenges remain, including varying positivity rates between providers, discrepancies in variant classification (especially for variants of unknown...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-